lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CAMP4 Therapeutics
CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
May 14, 2026
CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights
May 7, 2026
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
May 4, 2026
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 3, 2026
CAMP4 Appoints Michael MacLean to its Board of Directors
April 30, 2026
CAMP4 to Participate in Upcoming Investor Conferences
March 6, 2026
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
March 5, 2026
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 20, 2026